KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $136000.0.

  • Guardant Health's Tax Provisions rose 35333.33% to $136000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 427037.04%. This contributed to the annual value of $1.3 million for FY2024, which is 8744.53% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Tax Provisions is $136000.0, which was up 35333.33% from $38000.0 recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Tax Provisions registered a high of $716000.0 during Q4 2024, and its lowest value of -$541000.0 during Q4 2023.
  • In the last 5 years, Guardant Health's Tax Provisions had a median value of $133000.0 in 2024 and averaged $203789.5.
  • Its Tax Provisions has fluctuated over the past 5 years, first skyrocketed by 537272.73% in 2022, then tumbled by 18986.71% in 2023.
  • Over the past 5 years, Guardant Health's Tax Provisions (Quarter) stood at $11000.0 in 2021, then skyrocketed by 5372.73% to $602000.0 in 2022, then plummeted by 189.87% to -$541000.0 in 2023, then surged by 232.35% to $716000.0 in 2024, then plummeted by 81.01% to $136000.0 in 2025.
  • Its Tax Provisions was $136000.0 in Q3 2025, compared to $38000.0 in Q2 2025 and $290000.0 in Q1 2025.